239 related articles for article (PubMed ID: 28087178)
1. Acupuncture for serum uric acid in patients with asymptomatic hyperuricemia: A randomized, double-blind, placebo-controlled trial.
Huang Y; Meng J; Sun B; Xiang T; Zhou X; Xu B; Wu Y; Chen Z; Zhang S
Int J Cardiol; 2017 Apr; 232():227-232. PubMed ID: 28087178
[TBL] [Abstract][Full Text] [Related]
2. Acupuncture of the Five Shu Acupoints in spleen meridian to lower blood uric acid level.
Sun BG; Meng J; Xiang T; Chen ZX; Zhang SJ
Ann Palliat Med; 2014 Jan; 3(1):22-7. PubMed ID: 25841485
[TBL] [Abstract][Full Text] [Related]
3. [Effect of acupuncture stimulation of "Shenshu"(BL23)-"Taixi"(KI3)on levels of serum uric acid and renal URAT1 and OAT1 protein expression in hyperuricemia rats].
Liu XF; Chen HY; Wang J; Yun S; He XQ; Tang XQ; Sui MH
Zhen Ci Yan Jiu; 2019 May; 44(5):319-23. PubMed ID: 31155862
[TBL] [Abstract][Full Text] [Related]
4. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268
[TBL] [Abstract][Full Text] [Related]
6. A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for Evaluation of the Efficacy and Safety of DKB114 on Reduction of Uric Acid in Serum.
Park YH; Kim DH; Lee JS; Jeong HI; Lee KW; Kang TH
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322063
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the effectiveness and safety of acupuncture on serum uric acid in asymptomatic hyperuricemia population: a randomized controlled clinical trial study protocol.
Yu LL; Li CN; Fang MY; Ma Y; Wang B; Lin FP; Liu WH; Tu SH; Chen Z; Xie WX; Zhang RY; Huang Y; Zheng CH; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1218546. PubMed ID: 37900149
[TBL] [Abstract][Full Text] [Related]
8. Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Oshima S; Shiiya S; Nakamura Y
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30845731
[TBL] [Abstract][Full Text] [Related]
9. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
[TBL] [Abstract][Full Text] [Related]
10. [Study on mechanism of Fangji Huangqi Decoction on hypouricemic effect and renal protection in hyperuricemia mice].
Xing W; Ning X; Hong-Lei LI; Zhen C; Wan YU
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5248-5255. PubMed ID: 33350242
[TBL] [Abstract][Full Text] [Related]
11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266
[TBL] [Abstract][Full Text] [Related]
13. Effects of
Lee S; Han EH; Lee SH; Lim MK; Kim CO; Kang S
J Med Food; 2020 May; 23(5):508-514. PubMed ID: 32150484
[No Abstract] [Full Text] [Related]
14. Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.
Rozza F; Trimarco V; Izzo R; Grassi D; Ferri C
High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):381-386. PubMed ID: 27644242
[TBL] [Abstract][Full Text] [Related]
15. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
[TBL] [Abstract][Full Text] [Related]
16. Acupuncture to treat asymptomatic hyperuricemia: A protocol for systematic review and meta-analysis of randomized controlled trials.
Hwang JH; Lee KH; Nam DW; Song HS
Medicine (Baltimore); 2021 Feb; 100(6):e24719. PubMed ID: 33578616
[TBL] [Abstract][Full Text] [Related]
17. Effect of Oral Vitamin C Supplementation on High-Altitude Hyperuricemia in Young Men Initially Migrating to High Altitude: A Pilot Study.
Peng H; Feng D; Wang Y; Dong Z; Chen Q; Zhang L; Luo R; Chen J; Wang A; Ma S
High Alt Med Biol; 2018 Dec; 19(4):373-381. PubMed ID: 30358417
[TBL] [Abstract][Full Text] [Related]
18. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study.
Hosoya T; Sasaki T; Hashimoto H; Sakamoto R; Ohashi T
J Clin Pharm Ther; 2016 Jun; 41(3):298-305. PubMed ID: 27079434
[TBL] [Abstract][Full Text] [Related]
20. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
